Follow the 바이오인프라 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오인프라 has recorded 12 insider filings. The latest transaction was reported on 8 June 2026 (Purchase). Among the most active insiders: 김장현. All data is accessible without an account.
12
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
7 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.